We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » UK Watchdog Claims Concordia Overcharged for Thyroid Meds
UK Watchdog Claims Concordia Overcharged for Thyroid Meds
The UK’s competition watchdog agency claimed the drugmaker Concordia overcharged the NHS by millions for its hypothyroid medication liothyronine, also known as Cytomel, following price increases of almost 6,000 percent over a decade.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor